Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Central hyposomatotropism and hypothyroidism have been inferred in long-stay intensive care patients. Pronounced hypoandrogenism presumably also contributes to the catabolic state of critical illness. Accordingly, the present study appraises the mechanism(s) of failure of the gonadotropic axis in prolonged critically ill men by assessing the effects of pulsatile GnRH treatment in this unique clinical context. To this end, 15 critically ill men (mean ± sd age, 67 ± 12 yr; intensive care unit stay, 25 ± 9 days) participated, with baseline values compared with those of 50 age- and BMI-matched healthy men. Subjects were randomly allocated to 5 days of placebo or pulsatile iv GnRH administration (0.1 μg/kg every 90 min). LH, GH, and TSH secretion was quantified by deconvolution analysis of serum hormone concentration-time series obtained by sampling every 20 min from 2100–0600 h at baseline and on nights 1 and 5 of treatment. Serum concentrations of gonadal and adrenal steroids, T4, T3, insulin-like growth factor I (IGF), and IGF-binding proteins as well as circulating levels of cytokines and selected metabolic markers were measured. During prolonged critical illness, pulsatile LH secretion and mean LH concentrations (1.8 ± 2.2 vs. 6.0 ± 2.2 IU/L) were low in the face of extremely low circulating total testosterone (0.27 ± 0.18 vs. 12.7 ± 4.07 nmol/L; P < 0.0001) and relatively low estradiol (E2; 58.3 ± 51.9 vs. 85.7 ± 18.6 pmol/L; P = 0.009) and sex hormone-binding globulin (39.1 ± 11.7 vs. 48.6 ± 27.8 nmol/L; P = 0.01). The molar ratio of E2/T was elevated 37-fold in ill men (P < 0.0001) and correlated negatively with the mean serum LH concentrations (r =− 0.82; P = 0.0002). Pulsatile GH and TSH secretion were suppressed (P ≤ 0.0004), as were mean serum IGF-I, IGF-binding protein-3, and acid-labile subunit concentrations; thyroid hormone levels; and dehydroepiandrosterone sulfate. Morning cortisol was within the normal range. Serum interleukin-1β concentrations were normal, whereas interleukin-6 and tumor necrosis factor-α were elevated. Serum tumor necrosis factor-α was positively correlated with the molar E2/testosterone ratio and with type 1 procollagen; the latter was elevated, whereas osteocalcin was decreased. Ureagenesis and breakdown of bone were increased. C-Reactive protein and white blood cell counts were elevated; serum lactate levels were normal. Intermittent iv GnRH administration increased pulsatile LH secretion compared with placebo by an increment of +8.1 ± 8.1 IU/L at 24 h (P = 0.001). This increase was only partially maintained after 5 days of treatment. GnRH pulses transiently increased serum testosterone by +174% on day 2 (P = 0.05), whereas all other endocrine parameters remained unaltered. GnRH tended to increase type 1 procollagen (P = 0.06), but did not change serum osteocalcin levels or bone breakdown. Ureagenesis was suppressed (P < 0.0001), and white blood cell count (P = 0.0001), C-reactive protein (P = 0.03), and lactate level (P = 0.01) were increased by GnRH compared with placebo infusions. In conclusion, hypogonadotropic hypogonadism in prolonged critically ill men is only partially overcome with exogenous iv GnRH pulses, pointing to combined hypothalamic-pituitary-gonadal origins of the profound hypoandrogenism evident in this context. In view of concomitant central hyposomatotropism and hypothyroidism, evaluating the effectiveness of pulsatile GnRH intervention together with GH and TSH secretagogues will be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approximate entropy as a measure of system complexity.
Pincus, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2297 · Cited by 5,811 · cited 2×
“Normal estimated free E2 levels in the presence of dramatically low serum concentrations of its precursors T and DHEA indicate increased aromatase activity, which at the pituitary level may contribute to the impairment of pulsatile LH secretion (27) and to desensitization of the gonadotropes despite sustained exogenou…”
BackgroundRivier, C., Rivier, J., & Vale, W. (1986) · Science · doi:10.1126/science.3003907 · Cited by 531
Transient hypogonadotropic hypogonadism caused by critical illness
WOOLF, P. D., HAMILL, R. W., McDONALD, J. V., LEE, L. A., & KELLY, M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-444 · Cited by 338
Aromatization of Androgens by Human Abdominal and Breast Fat Tissue1
NIMROD, A., & RYAN, K. J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-3-367 · Cited by 314
Mulligan, T., Iranmanesh, A., Kerzner, R., Demers, L., & Veldhuis, J. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410257 · Cited by 121
Self-citationSpratt, D. I., Bigos, S. T., Beitins, I., Cox, P., Longcope, C., & Orav, J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464665 · Cited by 118
Stratakis, C. A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1348 · Cited by 115
Attenuated release of biologically active luteinizing hormone in healthy aging men.
Urban, R. J., Veldhuis, J. D., Blizzard, R. M., & Dufau, M. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113412 · Cited by 93 · cited 1×
“and Leydig cell tumors (52, 60, 61), in the aromatase excess syndrome (62), and during iv infusion of E2 (51, 63).”
BackgroundSelf-citationFryburg, D. A., Weltman, A., Jahn, L. A., Weltman, J. Y., Samojlik, E., Hintz, R. L., & Veldhuis, J. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4379 · Cited by 64
Self-citation
Cited by
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Jeng, L., Yamshchikov, A. V., Judd, S. E., Blumberg, H. M., Martin, G. S., Ziegler, T. R., & Tangpricha, V. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-28 · Cited by 440
Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill*
Braun, A., Chang, D., Mahadevappa, K., Gibbons, F. K., Liu, Y., Giovannucci, E., & Christopher, K. B. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206ccdf · Cited by 349
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
Qaseem, A., Humphrey, L. L., Chou, R., Snow, V., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00007 · Cited by 334
Metadata
- Authors
- Van den Berghe, G., Weekers, F., Baxter, R. C., Wouters, P., Iranmanesh, A., Bouillon, R., & Veldhuis, J. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-07-01
- Volume
- 86
- Issue
- 7
- Pages
- 3217-3226
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102665063
- Cited by
- 116
- References
- 9
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1. https://app.cochat.ai/papers/10.1210/jcem.86.7.7680
- The paper
- Van den Berghe, G., Weekers, F., Baxter, R. C., Wouters, P., Iranmanesh, A., Bouillon, R., & Veldhuis, J. D. (2001). Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.7.7680
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.